Related Experiment Videos
Primary pulmonary hypertension in adults
1Section of Cardiovascular Diseases, University of Kansas Medical Center, Kansas City 66103.
Clinical Cardiology
|June 1, 1990
Summary
Primary pulmonary hypertension (PPH) is a rare disease affecting predominantly young women, with insidious onset and disappointing treatment options. Current treatments offer limited success, and heart-lung transplantation is reserved for a few young patients.
Area of Science:
- Cardiology
- Pulmonology
- Pathology
Background:
- Primary pulmonary hypertension (PPH) is an enigmatic disease.
- It predominantly affects young women but also impacts middle-aged and elderly individuals.
- The disease onset is insidious, with symptoms like dyspnea, fatigue, and chest pain.
Purpose of the Study:
- To review the histopathology, evaluation, treatment, and prognosis of primary pulmonary hypertension.
- To provide a comprehensive overview of PPH for clinicians and researchers.
- To highlight the challenges in managing this rare condition.
Main Methods:
- Review of existing literature on primary pulmonary hypertension.
- Analysis of histopathologic subtypes and natural disease progression.
- Evaluation of current and emerging treatment strategies.
Main Results:
- Three distinct histopathologic subtypes of PPH have been identified.
- The natural history of PPH is well-defined.
- Pharmacologic treatment options have generally been disappointing.
Conclusions:
- Primary pulmonary hypertension remains a significant clinical challenge.
- Heart-lung transplantation is a viable option for a small subset of young patients.
- Further research into effective treatments for PPH is warranted.